24.08.2013 Views

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Prenatal and perinatal genetics<br />

and Gynecology, Ankara, Turkey.<br />

First- and second-trimester ultrasonographic (USG) findings <strong>of</strong> fetal<br />

chromosome abnormalities include structural abnormalities and/or sonographic<br />

markers <strong>of</strong> fetal aneuploidy. Sonographic markers <strong>of</strong> fetal<br />

aneuploidy may be seen in normal fetuses and are <strong>of</strong>ten transient.<br />

We aimed to evaluate the importance <strong>of</strong> USG findings, in estimating<br />

cytogenetic abnormality risks in low aneuploidy risk pregnancies. We<br />

reviewed a number <strong>of</strong> most commonly accepted markers and structural<br />

abnormalities on pregnant women with low risk who underwent<br />

invasive prenatal diagnostic tests for USG abnormality in the period<br />

from January 2002 to December 2008. Prenatal genetic diagnosis <strong>of</strong><br />

68 cordocenteses, 42 chorionic villus samples (CVS) and 1688 amniocenteses<br />

(AS) were performed. In 179 <strong>of</strong> all cases (9.95%), cytogenetic<br />

analysis was recommended because <strong>of</strong> USG abnormality. 82<br />

patients had structural abnormalities and 97 had sonographic markers.<br />

We detected 10 aneuploidies in fetuses with structural abnormalities<br />

and 3 aneuploidies in fetuses with sonographic markers, as expected.<br />

We concluded that, although the presence or absence <strong>of</strong> sonografic<br />

markers can substantially modify the risk <strong>of</strong> fetal aneuploidy, structural<br />

abnormalities inevitably have high risk for aneuplodies.<br />

P05.13<br />

Prenatal Detection <strong>of</strong> Pericentric inversion <strong>of</strong> chromosome 9 in<br />

5358 Referrals at a Reference Genetic center<br />

E. Karaca, E. Pariltay, O. Cogulu, H. Akin, F. Ozkinay;<br />

Ege University, Faculty <strong>of</strong> Medicine, Izmir, Turkey.<br />

Pericentric inversion <strong>of</strong> chromosome 9 is a structural chromosomal<br />

variant which usually has no phenotypic effect and occurs 1.98 % in<br />

human population. In this study, we report on the incidence <strong>of</strong> pericentric<br />

inversions <strong>of</strong> chromosome 9, the indications <strong>of</strong> those results,<br />

and discuss the data in the light <strong>of</strong> the literature. We have reviewed<br />

the results <strong>of</strong> a total <strong>of</strong> 5358 pregnant women who underwent invasive<br />

prenatal procedures between January 1998 and December 2008.<br />

Inversion <strong>of</strong> chromosome 9 was detected in 60 <strong>of</strong> them (1.1%). The<br />

most common indications were advanced maternal age (AMA) [n: 27,<br />

(45%)], high risk result on triple test (HRRTT) [n: 14, (24%)], anomalies<br />

in USG examination [n: 10, (16%)], increased nuchal translucency [n:<br />

4, (7%)], and other reasons in 5 (8%)[n: 5, (8%)]. In conclusion the<br />

incidence <strong>of</strong> prenatally detected pericentric inversion <strong>of</strong> chromosome<br />

9 is compatible with the incidence <strong>of</strong> general population.<br />

P05.14<br />

Leptin gene (tttc) n microsatellite polymorphism in preeclampsia<br />

and HELLP syndrome<br />

B. Nagy, T. Varkonyi, L. Lazar, P. Hupuczi, N. G. Than, J. Rigo Jr;<br />

1st Dept. <strong>of</strong> Obstetrics and Gynecology, Semmelweis University, Budapest,<br />

Hungary.<br />

Genetic variation on the leptin gene (LEP) influences susceptibility to<br />

obesity. A study showed correlation between the length <strong>of</strong> the microsatellite<br />

on the LEP gene and pre-eclampsia. We decided to compare the<br />

tetranucleotide repeat (TTTC) n polymorphism in the 3’-flanking region<br />

in the leptin gene on DNA samples <strong>of</strong> patients with pre-eclampsia and<br />

HELLP syndrome. Blood samples were collected from normal pregnant<br />

(n=71), pre-eclamptic (n=64) and HELLP (n=69) syndrome patients.<br />

Fluorescent PCR and DNA fragment analyses was performed from<br />

isolated DNA. The electrophoretograms were evaluated and patients<br />

were assigned to two groups, class I low (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!